Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Firm Income Reported for This Client
$10K
Not substituted for client expenses
Summary
GENLANTIS (DIVISION OF GENE THERAPY SYSTEMS INC ) is an organization, based in CA. Its political footprint includes $10K in lobbying-firm income reported for this client. Lobbying activity focuses on Budget/Appropriations.